Genome-wide association study identifies five susceptibility loci for glioma
By S. Shete, Fay J. Hosking, Lindsay B. Robertson, S. Dobbins, M. Sanson, B. Malmer, M. Simon, Y. Marie, B. Boisselier, Jean-Yves Delattre and 27 more. Nature Genetics, 2009
810 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics
View Paper: https://www.semanticscholar.org/paper/1c398d73f5ecce9eda751488d1c8cee002561a0a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Zefeng Wang
- R. Jenkins
- Peter W. Laird
- Charles M. Perou
- Eric C. Holland
- S. Baylin
- N. Sharpless
- McKinsey L. Goodenberger
In Genetics
- Peter W. Laird
- S. Baylin
- Hui Shen
- J. Herman
- Jill S. Barnholtz-Sloan
- R. Jenkins
- Richard K. Wilson
- Eric C. Holland
Citations in the corpus
- The epidemiology of glioma in adults: a "state of the science" review. (2014, methodology): “Ostrom et al.: The epidemiology of glioma in adults: a review 900 D ow nloaded from https://academ ic.oup.com /neuro-oncology/article-abstract/16/7/896/1927249 by guest on 16 M arch 2020 N eu ro-O n cology 9 0 1 D ow nloaded from https://academ ic.oup.com /neuro-oncology/article-abstract/16/7/896/19”
- Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (2010, background): “…MYC oncogene, is rich in sequence variants, and was previously shown as a risk factor for several human cancers (Amundadottir et al., 2006; Freedman et al., 2006; Haiman et al., 2007a; Haiman et al., 2007b; Schumacher et al., 2007; Shete et al., 2009; Visakorpi et al., 1995; Yeager et al., 2007).”
- Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk (2010, background): “We believe this work has implications beyond ASVD, as altered ANRIL splicing could influence INK4/ARF expression, explaining the association of other nearby 9p21 SNPs with a variety of non-ASVD phenotypes in humans including longevity, type II diabetes, endometriosis and several tumors types [70–77]”
- Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma (2010, background): “Moreover, recent genome-wide association screens have identified single nucleotide polymorphisms (SNPs) in the CDKN2A and adjacent CDKN2B loci as risk factors for glioma developmen”
- Genetics of adult glioma. (2012, background): “In 2009, two separate GWAS identified single nucleotide polymorphisms (SNPs) associated with the risk of glioma development (82,83).”